CABIRALIZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Investigational

Investigational

Approval Year

Name

Type

Language

CABIRALIZUMAB

Official Name

English

cabiralizumab [INN]

Preferred Name

English

IMMUNOGLOBULIN G4, ANTI-(MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL FPA008 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL FPA008 LIGHT CHAIN, DIMER

Common Name

English

Cabiralizumab [WHO-DD]

Common Name

English

FPA008

Common Name

English

FPA-008

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C20401

Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025

NCI_THESAURUS

C129822

Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025

FDA ORPHAN DRUG

502315

Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025

EU-Orphan Drug

EU/3/16/1799

Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025

Code System Code Type Description

SMS_ID

100000174820

Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025

PRIMARY

NCI_THESAURUS

C123831

Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025

PRIMARY

DRUG BANK

DB15082

Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025

PRIMARY

INN

10121

Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025

PRIMARY

CAS

1613144-80-1

Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025

PRIMARY

FDA UNII

5FJL6W0640

Created by admin on Mon Mar 31 22:51:22 GMT 2025 , Edited by admin on Mon Mar 31 22:51:22 GMT 2025

PRIMARY

ACTIVE MOIETY


					5FJL6W0640